Lauren Seeberger
Neurology · Charleston, WVNPI 1053305656
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Neurocrine Biosciences, Inc. accounts for 93.3% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $26,164, 6.7 times the $3,926 reported in 2019. Among neurology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $608.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$68K
- F. Hoffmann-la Roche AG$3K
- Boston Scientific$1K
- Merz Pharmaceuticals, LLC$211
- UCB, Inc.$99
- Genentech USA, Inc.$91
- plus $425 from 14 others
Across 112 payments — averaging $1938.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceutical Holding Company Ltd.$124K
- Neurocrine Biosciences, Inc.$53K
- Teva Pharmaceuticals USA, Inc.$26K
- Biohaven Pharmaceuticals, Inc.$14K
- F. Hoffmann-la Roche AG$490
What the payments were for
- Consulting fees$40,37356%
- Speaking & faculty fees$21,85830%
- Travel & lodging$6,6009%
- Food & beverage$3,5725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 78 | $67,543 |
| F. Hoffmann-la Roche AG | 2 | $2,608 |
| Boston Scientific | 9 | $1,426 |
| Merz Pharmaceuticals, LLC | 2 | $211 |
| UCB, Inc. | 2 | $99 |
| Genentech USA, Inc. | 1 | $91 |
| AbbVie | 4 | $60 |
| Amneal Pharmaceuticals LLC | 3 | $59 |
| Novartis | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Neurelis, Inc. | 2 | $30 |
| AstraZeneca | 2 | $30 |
| SK Life Science, Inc. | 1 | $21 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Argenx US, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Biogen | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$50,240
- ONGENTYS$7,584
- Non-Covered Product$2,608
- SPECTRA WAVEWRITER$1,046
- GENERAL DBS$199
- XEOMIN$163
How this compares
$72,403 in reported general payments places this provider in the 90th percentile of 93 neurology providers in West Virginia.
Other neurology in Charleston
- Muhammed Nasher-AlneamCharleston$73K
- Gregory MathewsCharleston$30K
- Suzanne CrandallCharleston$11K
- David LardizabalCharleston$10K
- Darshankumar DaveCharleston$3K
- Joby JosephCharleston$2K
- Kris MurthyCharleston$2K
- Carolyn NeffCharleston$1K
- Braydon DymmCharleston$895
- Farrukh ShaikhCharleston$468
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.